The disclosure controls weakness was remediated by Q3 2026, and the auditor's ICFR opinion was unqualified. No financial restatement or material weakness was identified. Monitor next 10-Q for confirmation that controls are effective.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 4 $13.79entry
- T+1 · 5d ago −7.54%α −3.13% · $12.75
- T+4 · todayOpen
- T+5 · in 13h Pending
- T+20 · in 23d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Chemours filed Amendment No. 1 to its 2025 10-K solely to correct an administrative error: Management's Report on Internal Control over Financial Reporting was inadvertently omitted from the original filing. The amendment restates Item 9A to include the omitted report and revises the disclosure controls conclusion to 'not effective' as of December 31, 2025 due to this error. The auditor's unqualified opinion on internal controls was already included in the original filing and is unaffected.
Key Facts
- Amendment filed solely to include inadvertently omitted Management's Report on Internal Control over Financial Reporting in Item 9A
- CEO and CFO now conclude disclosure controls were not effective as of Dec 31, 2025 due to the administrative error
- Ineffectiveness existed from Dec 31, 2025 until Q3 2026; additional review procedures implemented in Q3 2026
- Auditor PricewaterhouseCoopers LLP had already issued an unqualified opinion on ICFR effectiveness in the original filing
- No restatement of financial statements; no change to any financial data
- No change to auditor, no going concern language, no litigation risk from restatement
Financial Impact
No financial statement impact; purely a disclosure controls remediation.
Risk Factors
- Disclosure controls were ineffective for approximately nine months, increasing risk of non-financial disclosure errors in that period
- Administrative error in a large accelerated filer may attract SEC scrutiny or plaintiff attention, though no financial restatement occurred
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 10-K/A Filing (Primary) | 0001104659-26-122164 |
| Document: tm2628899d1_ex31-4.htm | 0001104659-26-122164 |
| Document: tm2628899d1_ex31-3.htm | 0001104659-26-122164 |
| Document: 0001104659-26-122164-index-headers.html | 0001104659-26-122164 |
| Document: 0001104659-26-122164-index.html | 0001104659-26-122164 |
| Document: 0001104659-26-122164.txt | 0001104659-26-122164 |
Track record
18 reports on CC
1 of 3 bullish or bearish reports moved the stock their way by T+20. Best: +14.25% at T+60 after the Aug 14, 2026 report. 1 of 4 went positive at some point.
Filters
- Nov 5, 20265d ago Institutional Cluster Mixed 3/10 Entry $12.75 Now $13.48 +5.73% settles Dec 4
- Nov 3, 20267d ago 10-K/A Neutral 3/10 Viewing Entry $13.79 Now $13.48 −2.25% settles Dec 3
- Nov 2, 20268d ago 8-K Bearish 5/10 No price data
- Nov 2, 20268d ago Press Release Bearish 5/10 Entry $13.09 Now $13.48 −2.98% settles Dec 2
- Oct 27, 202614d ago Press Release Neutral 2/10 Entry $13.36 Now $13.48 +0.90% settles Nov 25
- Oct 21, 202620d ago Press Release Neutral 1/10 Entry $13.03 Now $13.48 +3.45% settles Nov 19
- Sep 10, 20268w ago 8-K Bullish 7/10 Entry $15.07 to $13.83 Now $13.48 −10.55% ▼ −8.23% −10.35% vs SPY
- Sep 9, 20268w ago 8-K Neutral 3/10 Entry $15.04 to $13.98 Now $13.48 −10.37% ▼ −7.05% −9.24% vs SPY
- Aug 14, 202612w ago Institutional Cluster Bearish 5/10 Entry $15.72 to $14.68 Now $13.48 +14.25% ▲ +6.62% +4.64% vs SPY
- Aug 13, 202612w ago Insider Cluster Neutral 3/10 Entry $15.85 to $14.58 Now $13.48 −14.95% ▼ −8.01% −6.02% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers